The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Katunina E.A.

Department of Neurology, Neurosurgery and Medical Genetics of the Pirogov Russian National Research Medical University of the Ministry of Health of the Russia, Moscow, Russia

Titova N.V.

Kafedra nevrologii i neĭrokhirurgii lechebnogo fakul'teta Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

Avakian G.N.

Department of Neurology and Neurosurgery of the N.I. Pirogov Russian National Research Medical University

Methods of diagnosis early stage of Parkinson's disaese

Authors:

Katunina E.A., Titova N.V., Avakian G.N.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(12): 112‑118

Views: 12286

Downloaded: 298

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Katunina EA, Titova NV, Avakian GN. Methods of diagnosis early stage of Parkinson's disaese. S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(12):112‑118. (In Russ.)

 
МСФ на ЯМ
Close metadata
Recommended articles:
Criteria of syndrome frailty in Parkinson´s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):52-56
Tremor-dominant form of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):28-35
Nocturia in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):48-54
The normal sono­graphic picture of the para­tonsillar region and the prerequisites for ultrasound diagnosis of puru­lent pathology of the pharynx. Russian Bulletin of Otorhinolaryngology. 2024;(1):4-9
Methods of pancreatic fibrosis asse­ssment. Russian Journal of Evidence-Based Gastroenterology. 2024;(1):48-57
Comparison of the clinical performance of immu­nochromatographic tests for the dete­ction of SARS-CoV-2 anti­gens with data from inde­pendent studies. Labo­ratory Service. 2024;(1):13-19
Pathogenetic, clinical-diagnostic and therapeutic aspe­cts of premenstrual syndrome. Russian Bulletin of Obstetrician-Gynecologist. 2024;(2):37-42
Traumatic damage to the diaphragm in children. Piro­gov Russian Journal of Surgery. 2024;(4):64-68
Resu­lts of inva­sive diagnosis of primary mali­gnant bone tumors of the pelvis. P.A. Herzen Journal of Onco­logy. 2024;(2):9-14
Anesthesia for adults in outpatient surgery. Russian Journal of Anesthesiology and Reanimatology. 2024;(2):6-31

Keywords:

Parkinson disease
early stades
diagnostic biomarkers

Authors:

Katunina E.A.

Department of Neurology, Neurosurgery and Medical Genetics of the Pirogov Russian National Research Medical University of the Ministry of Health of the Russia, Moscow, Russia

Titova N.V.

Kafedra nevrologii i neĭrokhirurgii lechebnogo fakul'teta Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

Avakian G.N.

Department of Neurology and Neurosurgery of the N.I. Pirogov Russian National Research Medical University

List of references:

  1. Avakyan G.N., Voronina T.A., Val'dman E.L. i dr.Kliniko-neirofiziologicheskoe i eksperimental'noe izuchenie osobennostei primeneniya sul'fata adamantana pri bolezni Parkinsona. Zhurn nevrol i psikhiat 2004; 104: 9: 18-22.
  2. Artem'ev D.V., Damulin I.V., Ternovoi S.K. i dr.Magnitno-rezonansnaya tomografiya golovnogo mozga pri bolezni Parkinsona. Zhurn nevrol i psikhiat 1993; 93: 6: 27-29.
  3. Badalyan L.O., Skvortsov I.A.Klinicheskaya elektromiografiya. M: Meditsina 1986; 368.
  4. Baziyan B.Kh., Chigaleichik L.A., Dmitriev I.E.Vozmozhnye mekhanizmy narushenii sakkadicheskikh dvizhenii glaz u patsientov s bolezn'yu Parkinsona. Byul eksper biol 1998; 125: 3: 254-259.
  5. Bezdol'nyi Yu.N.Kliniko-epidemiologicheskie osobennosti razlichnykh form parkinsonizma: Avtoref. dis. … kand. med. nauk. M 2010; 140.
  6. Bogdanov R.R.Diagnostika i terapiya rannikh proyavlenii bolezni Parkinsona: Avtoref. dis. … kand. med .nauk. M 2006; 159.
  7. Vainshtok A.B., Timko N.A.Opredelenie skorosti provedeniya vozbuzhdeniya po perifericheskim nervam u bol'nykh parkinsonizmom. Zhurn nevrol i psikhiat 1971; 71: 7: 972-976.
  8. Vein A.M., Golubev V.L., Berzin'sh Yu.E.Parkinsonizm Riga: Zinante 1981; 328.
  9. Gaponova Yu.G.Bioelektricheskaya aktivnost' golovnogo mozga pri parkinsonizme i ee znachenie v kliniko-ekspertnoi otsenke bol'nykh. Sbornik trudov TsIETIN, vyp. 1. Elektrofiziologicheskie issledovaniya v praktike vrachebno-trudovoi ekspertizy. M 1972; 139-148.
  10. Golubev V.L., Levin Ya.I., Shamlikashvili Ts.A.Lateralizovannye formy parkinsonizma (klinicheskie, elektrofiziologicheskie i psikhomotornye aspekty). Zhurn nevrol i psikhiat 1989; 11: 119-123.
  11. Elkin M.N., Zenkov L.R.Kolichestvennyi analiz EEG pri bolezni Parkinsona i postsinapticheskom parkinsonizme. Vserossiiskii s''ezd nevrologov, 7-i: Materialy. N. Novgorod 1995; 553.
  12. Zenkov L.R., Elkin M.N., Medvedev G.A.Klinicheskaya neirofiziologiya neirogeriatricheskikh rasstroistv. V sb.: Dostizheniya v neirogeriatrii. M 1995; 2: 157-175.
  13. Karaban' I.N.Vozrastnye osobennosti ekstrapiramidnoi nedostatochnosti pri starenii i parkinsonizme: Avtoref. dis. …d-ra med. nauk. Kiev 1990; 38.
  14. Kilimov I., Fililova D.Izsledovane na N-refleks sled seriya ot stimuli u zdravi i bolni s parkinsonov sindrom. Nevrol psikhiat nevrokhir (Sofiya) 1978; 17: 6: 366-371.
  15. Koberskaya N.N.Kliniko-elektrofiziologicheskie kharakteristiki kognitivnykh narushenii pri bolezni Parkinsona i simptomaticheskom parkinsonizme: Avtoref. dis. …. kand. med. nauk. M 2003; 26.
  16. Kryzhanovskii G.N., Karaban' I.N., Magaeva S.V. i dr.Bolezn' Parkinsona (etiologiya, patogenez, klinika, diagnostika, lechenie, profilaktika). M: Meditsina 2002; 336.
  17. Levin O.S.Kliniko-neiropsikhologicheskie i neirovizualizatsionnye aspekty differentsial'noi diagnostiki parkinsonizma: Avtoref. dis. ... d-ra med. nauk. M 2003; 403.
  18. Litvinenko I.V.Bolezn' Parkinsona. M: Miklosh 2006; 216.
  19. Lupandin Yu.V., Antonen E.G., Meigal A.Yu.Patterny bioelektricheskoi aktivnosti dvigatel'nykh edinits pri raznykh formakh parkinsonizma. Zhurn nevrol i psikhiat 1993; 93: 6: 30-34.
  20. Mamysheva O.D.Perifericheskie mekhanizmy parkinsonizma. Patogenez, klinika i lechenie parkinsonizma: Tezisy dokladov. Dnepropetrovsk 1978; 47-49.
  21. Man'kovskii N.B., Vainshtok A.B., Oleinik L.I.Rol' spinal'nykh mekhanizmov v vozniknovenii vozrastnykh izmenenii myshechnogo tonusa. Gerontologiya i geriatriya. Ezhegodnik. Oporno-dvigatel'naya sistema. Kiev 1980; 103-107.
  22. Man'kovskii N.B., Vainshtok A.B., Oleinik L.I.Sosudistyi parkinsonizm. Kiev: Zdorov'ya 1982; 208.
  23. Macheret E.L., Zamost'yan V.P., Lysenok V.P.Starenie i dvigatel'nye vozmozhnosti. Kiev: KGU 1989; 173.
  24. Mikhailenko A.A.Porazheniya ekstrapiramidnoi sistemy. V kn.: Differentsial'naya diagnostika nervnykh boleznei. St-Peterburg: Gippokrat 2000; 6: 87-106.
  25. Oleinik L.I.O roli spinal'nykh mekhanizmov v geneze myshechnoi rigidnosti pri parkinsonizme. Patogenez, klinika i lechenie parkinsonizma. M 1978; 63-65.
  26. Petelin L.S.Ekstrapiramidnye giperkinezy. M: Meditsina 1970; 260.
  27. Sadikova O.N.Korrelyatsiya klinicheskikh, neiropsikhologicheskikh i komp'yuterno-tomograficheskikh dannykh pri bolezni Parkinsona: Avtoref. dis. ... kand. med. nauk. M 1997; 164.
  28. Selikhova M.V.Klinicheskie osobennosti i patogenez rannego perioda bolezni Parkinsona. Differentsirovannyi podkhod k lecheniyu: Avtoref. dis. … dokt. med. nauk. M 2004; 301.
  29. Starikov A.S.Elektricheskaya vozbudimost' perifericheskogo dvigatel'nogo neirona pri parkinsonizme. Zhurn nevrol i psikhiat 1993; 93: 6: 11-15.
  30. Starikov A.S.Neirofiziologicheskii analiz parkinsonizma. Ros med-biol vestn im. I.P. Pavlova 1999; 1-2: 81-87.
  31. Starikov A.S.Neirofiziologicheskii i neiromorfologicheskii analiz bolezni Parkinsona i ee lechenie stereotaksicheskim metodom. Zhurn nevrol i psikhiat 2004; 104: 11: 29-33.
  32. Starobinets M.Kh., Volkova L.D.O primenenii stimulyatsionnoi elektroneiromiografii: Obzor. Zhurn nevropatol i psikhiat 1981; 5: 753-768.
  33. Chekhonin V.P., Baklaushev V.P., Kogan B.M. i dr.Katekholaminy i ikh metabolity v mozge i moche u krys s eksperimental'nym parkinsonizmom. Byul eksp biol i med 2000; 130: 8: 805-809.
  34. Chukhrova V.A.Izmenenie elektricheskoi aktivnosti mozga pri nekotorykh zabolevaniyakh tsentral'noi nervnoi sistemy s preimushchestvenno podkorkovoi lokalizatsiei patologicheskogo protsessa: Avtoref. dis. ... kand. med. nauk. M 1960; 150.
  35. Shul'govskii V.V., Turbina L.G., Napalkov D.A. i dr.Lateralizatsiya narushenii sakkadicheskikh dvizhenii glaz na rannikh stadiyakh bolezni Parkinsona. Konferentsiya "Strukturno-funktsional'nye i neirokhimicheskie zakonomernosti asimmetrii i plastichnosti mozga": Materialy. M 2006.
  36. Yakhno N.N., Damulin I.V., Goncharov O.A.Sravnitel'naya otsenka razlichnykh form parkinsonizma u bol'nykh pozhilogo i starcheskogo vozrasta (klinicheskoe, neiropsikhologicheskoe i komp'yuterno-tomograficheskoe issledovanie). Zhurn nevrol i psikhiat 1992; 1: 67-72.
  37. Adam P.Cortical atrophy in Parkinson's disease: correlation between clinical and CT findings with special and emphasis on prefrontal atrophy. Am J Neuroradiol 1983; 4: 3: 442-445.
  38. Al-Bunyan M.A.Parkinson's disease. Clinical and electrophysiological evaluation. Saudi Med J 2000; 21: 1: 72-75.
  39. Bain P.Are neurophysiological techniques useful in differentiating tremor? In: L.J. Findley, W.C. Koller (eds.). Handbook of Tremor Disorders. New York: Marcel Dekker Inc 1995; 79-93.
  40. Baldereschi M., Di Carlo A., Rocca W.A., Vanni P.Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. Italian Longitudinal Study on Aging. Neurology 2000; 11: 1358-1363.
  41. Berendse H.W., Stam C.J.Stage-dependent patterns of disturbed neural synchrony in Parkinson's disease. Parkinsonism and Related Disorders 2007; 13: 440-445.
  42. Berg D.Ultrasound in the (premotor) diagnosis of Parkinson's disease. Parkinsonism and Related Disorders 2007; 13: 429-433.
  43. Berg D., Roggendorf W., Schroder U. et al.Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 2002; 59: 999-1005.
  44. Berg D., Siefker C., Becker G.Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J Neurol 2001; 8: 684-689.
  45. Bhaskar P.A., Vanchilingam S., Bhaskar A.E. et al.Effect of L-dopa on visual evoked potential in patients with Parkinson's disease. Neurology 1986; 36: 1119.
  46. Birmingham A.T., Wharrad H.J., Williams E.J.The variation of finger tremor with age in man. J Neurol Neurosug Psychyat 1985; 48: 788-798.
  47. Booij J., Tissingh G., Winogrodzka A., van Royen E.A.Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism. Eur J Nucl Med 1999; 26: 171-182.
  48. Bosboom J., Staffers D., Stam C. et al.Resting state oscillatory brain dynamics in Parkinson's disease: an MEG study. Clin Neurophysiol 2006; 117: 2521-2531.
  49. Braak H., Ghebremedhin E. et al.Stages of the development of Parkinson's disease-related pathology. Cell Tissue Res 2004; 318: 121-134.
  50. Brooks D.J.Detection of preclinical Parkinson's disease with PET. Neurology 1991; 41: 24-27.
  51. Brooks D.J.The early diagnosis of Parkinson's disease. Eds.: C.W. Olanow, P. Jenner. Beyond the decade of the brain. Neuroprotection in Parkinson's disease. Kent: Wells Medical Limited 1998; 3: 37-41.
  52. Brooks D.J.Morphological and functional imaging studies on the diagnosis and progression of Parkinson's disease. J Neurol 2000; 247: Suppl 2: II/11-II/18.
  53. Buttner Th., Kuhn W., Muller Th. et al.Chromatic and achromatic visual evoked potentials in Parkinson's disease. Electroencephalography and Clinical Neurophysiology. Evoked Potentials Section 1996;100: 5: 443-447.
  54. Campenhausen S., Bornschein B.Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsychopharmacol 2005; 15: 473-490.
  55. Caronti B., Antonini G., Calderaro C. et al.Dopamine transporter immunoreactivity in peripheral blood lymphocytes in Parkinson's disease. J Neural Transm 2001; 108: 7: 803-807.
  56. Caronti V., Tanda G., Colosimo C. et al.Reduced dopamine in peripheral blood lymphocytes in Parkinson's disease. Neuroreport 1999; 10: 14: 2907-2910.
  57. Chan F., Armstrong I.T., Pari G. et al.Deficits in saccadic eye-movement control in Parkinson's disease. Neuropsychologia 2005; 43: 5: 784-796.
  58. Deng Q., Deng J., Zhao Y. et al.Analysis of brain-stem auditory evoked potential and visual evoked potential in patients with Parkinson disease. Neural regeneration research 2006; 1: 5: 74-96.
  59. Dioszeghy P., Hidasi E., Mechler F.Study of central motor functions using magnetic stimulation in PD. Electromyogr Clin Neurophysiol 1999; 39: 2: 101-105.
  60. Drory V.E., Inzelberg R., Groozman G.B., Korczyn A.D.N30 somatosensory evoked potentials in patients with unilateral Parkinson's disease. Acta Neurologica Scandinavica 1998; 97: 2: 73-76.
  61. Eisen A.A., Shtybel W.Clinical experience with transcranial magnetic stimulation. Muscle Nerve 1990; 13: 995-1011.
  62. Garkavenko V.V., Karaban I.N., Voloshin M.Ya. et al.Parkinson's disease and aging: Changes of somatosensory evoked potentials in humans. Neurophysiology 1994; 26: 3: 141-145.
  63. Grundig E., Gerstenbrand F.Correlation between Parkinsonism symptoms and a disorder in the amino acid metabolism in CNS. Wien Klin Wochenschr 1970; 82: 811-816.
  64. Haas R.H., Nasirian F., Nakano K. et al.Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's Disease. Ann Neurol 1995; 37: 714-722.
  65. Hammond C., Bergman H., Brown P.Pathological synchronization in Parkinson's disease: networks, models and treatments. Trends Neurosci 2007; 30: 357-364.
  66. Hallett M.Physiology of basal ganglia disorders: an overview. Can J Neurol Sci 1993; 20: 177-183.
  67. Hawkes C.H., Shephard B.C.Olfactory evoked responses and identification tests in neurological disease. Ann NY Acad Sci 1998; 30: 855: 608-615.
  68. Hawkes C.H., Shephard B.C., Daniel S.E.Olfactory dysfunction in Parkinson's disease. J Neurol Neurosurg Psychiat 1997; 62: 436-446.
  69. Hawkes C.H., Shephard B.C., Daniel S.E.Is Parkinson's disease a primary olfactory disorder? An Int J Med 1999; 92: 8: 473-480.
  70. Henderson J.M., Lu Y., Wang S. et al.Olfactory deficits and sleep disturbances in Parkinson's disease: a case-control survey. J Neurol Neurosurg Psychiat 2003; 74: 956-958.
  71. Hisao T., Masanaka T., Minoru S.Short-Latency Somatosensory and Brainstem Auditory Evoked Potentials in Patients with Parkinson's Disease. Int J Neuroscie 1989; 44: 3-4: 321-326.
  72. Hoshiyama M., Kaneoke Y., Koike Y.Hypokinesia of associated movement in Parkinson's disease: a symptom in early stages of disease. J Neurol 1994; 241: 517-521.
  73. Hughes A.J., Ben-Shlomo Y., Daniel S.E., Lees A.J.What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study. Neurology 1992; 42: 6: 1142-1146.
  74. Hughes A.J., Daniel S.E., Kilford L., Lees A.J.Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinicopathological study of 100 cases. J Neurol Neurosurg Psychiat 1992; 55: 2: 181-184.
  75. Huttunen J., Homberg V., Lange H.W.Pre- and postcentral somatosensory evoked potentials in Huntington's disease: effects of stimulus repetition rate. J Neurol Sci 1993; 116: 2: 119-124.
  76. Iwasaki Y., Ikeda K., Shiojima T., Kinoshita M.Increased plasma concentrations of aspartate, glutamate and glycine in Parkinson's disease. Neurosci Lett 1992; 145: 175-177.
  77. Jasper H.H.Discussion on anatomical and physiological aspects of Parkinson's disease. J Neurosurg 1966; 24: 235-236.
  78. Kandler R.H., Jarrat J.A., Saga H.J. et al.Abnormalities of central motor conduction in Parkinson's disease. J Neurol Sci 1990; 100: 94-97.
  79. Kikuchi A., Takeda A., Onodera H. et al.Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy. Neurobiol Dis 2002; 9: 244-248.
  80. Koeppe R.A., Frey K.A., Vander Borght T.M. et al.Kinetic evaluation of [C-11]dihydrotetrabenazine (DTBZ) by dynamic PET: a marker for the vesicular dopamine transporter. J Cereb Blood Flow Metab 1995; 15: Suppl 1: 651.
  81. Kushnir M., Klein S., Rabey J.M.H-reflex behavior in Parkinson's disease patients. Effect of stimulus duration. Parkinsonism and related disorders 2000; 6: 243-246.
  82. Laihinen A., Ruottinen H., Rinne J.O. et al.Risk for Parkinson' disease: twin studies for the detection of asymptomatic subjects using [l8F]6-fluorodopa PET. J Neurol 2000; 247: Suppl 2: 11: 110-113.
  83. Lallement F., Rolland Y., Prunier C. et al.Is iron involved in patophysiology of multiple system atrophy? Mov Dis 2000; 15: Suppl 3: 207.
  84. Lee C.S., Samii A., Sossi V. et al.In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson' disease. Ann Neurol 2000; 47: 493-503.
  85. Mally J., Szalai G., Stone T.W.Changes in the concentration of amino acids in serum and cerebrospinal fluid of patients with Parkinson's disease. J Neurol Sci 1997; 151: 159-162.
  86. Marras S., Goldman S., Smith A. et al.Smell identification ability in twin pairs discordant for Parkinson's disease. Mov Dis 2005; 20: 687-693.
  87. Milanov I.Clinical and electromyographic examination of Parkinsonian tremor. Parcinsonism and Related Dis 2000; 6: 229-235.
  88. Mintz M., Tomer R., Radwan H., Myslobodsky M.S.Visual evoked potentials in hemiparkinsonism. Electroencephalography and Clin Neurophysiol 1981; 52: issue 6: 611-616.
  89. Moresco R.M., Volonte M.A., Messa S. et al.New perspectives on neurochemical effects of amantadine in the brain of parkinsonian patients: a PET - [(11)C]-raclopride study. J Neural Transm 2002; 109: 10: 1265-1274.
  90. Morrish P.K., Sawle G.V., Brooks D.J.An 18F-dopa PET and clinical study of the rate of progression in Parkinson's disease. Brain 1996; 119: 585-591.
  91. Nahmias C., Garnett E.S., Firnau G. et al.Striatal dopamine distribution in Parkinsonian patients during life. Neurol Sci 1985; 69: 223-230.
  92. Neufeld M.Y., Blumen S., Aitkin I. et al.EEG frequency analysis in dementia and nondemented parkinsonian patients. Dementia 1994; 5: 1: 23-28.
  93. Nightingale S., Mitchell K.W., Howe J.W.Visual evoked cortical potentials and pattern electroretinograms in Parkinson's disease and control subjects. J Neurol Neurosurg Psychiat 1986; 49: 11: 1280-1287.
  94. Okuda B., Tachibana H., Kawabata K. et al.Visual Evoked Potentials (VEPs) in Parkinson's Disease: Correlation of Pattern VEPs Abnormality with Dementia. Alzheimer Disease & Associated Dis 1995; 9: 2: 68-72.
  95. Ozden S.H., Akbostanci M.C., Yucesan C. et al.Visual evoked potentials in Parkinson's disease - correlation with clinical involvement. Clin Neurol and Neurosurg 2001; 103: 3: 147-150.
  96. Penn A.M., Roberts T., Hodder J. et al.Generalized mitochondrial dysfunction in Parkinson's disease detected by magnetic resonance spectroscopy of muscle. Neurology 1995; 45: 2097-2099.
  97. Piccini P., Burn D.J., Ceravolo R. et al.The role of inheritance in sporadic Parkinson' disease: evidence from a longitudinal study of dopaminergic function in twins. Ann Neurol 1999; 45: 577-582.
  98. Ponsen M.M., Stoffers D., Booij. J. et al.Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 2004; 56: 173-181.
  99. Rinne J.O., Laihinen A., Ruottinen H. et al.Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson disease: a PET study with [11S] raclopride. J Neurol Sci 1995; 132: 156-161.
  100. Sabbahi M., Etnyre V., Al-Jawayed I., Jancovic J.H-reflex recovery curves differentiate essential tremor, Parkinson's disease, and the combination of essential tremor and Parkinson's disease. Jk Clin Neurophysiol 2002; 19: 3: 245-251.
  101. Sabra A.F., Hallett M.Action tremor with alternating activity in antagonist muscels. Neurology 1984; 34: 151-156.
  102. Sakuma K., Nakashima K., Takahashi K.Olfactory evoked potentials in Parkinson's disease, Alzheimer's disease and anosmic patients. Psychiat and Clin Neuroscie 1996; 50: 1: 35-40.
  103. Sarnthein J., Jeanmonod D.High thalamocortical theta coherence in patients with Parkinson's disease. J Neurosci 2007; 27: 124-131.
  104. Seibyl J.P., Marek K.L., Quinlan D. et al.Decreased single-photon emission computed tomographic [123I]-CIT striatal uptake correlates with symptom severity in Parkinson's disease. Ann Neurol 1995; 38: 589-598.
  105. Schmidt K., Herms G.On the changes of the EEG basis rhythm in patients with Parkinson's syndrome before and after stereoencephalotomy. Acta Neurochir 1966; 15: 3/4: 173-181.
  106. Shiek A., Winkins S., Suresh K.. et al.Metabolic profiling of Parkinson's disease: evidence of biomarker from gene expression analysis and rapid neural network detection. J Biomed Scie 2009; 16.
  107. Soikkelli R., Partanen J., Soinen H.Slowing of EEG in Parkinsons disease. Electroenceph Clin Neurophysiol 1991; 79: 159-165.
  108. Sommer U., Hummel T., Cormann K. et al.Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT. Mov Dis 2004; 19: 1196-1202.
  109. Staffers D., Bosboom J.L., Deijen J.B. et al.Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia. Brain 2007; 130: 1847-1860.
  110. Starkstein S.E., Leiguarda R.Neuropsychological correlation of brain atrophy in Parkinson's disease: a CT-study. Mov Dis 1993; 8: 1: 51-55.
  111. Stoessl A.J.Positron emission tomography in premotor Parkinson's disease. Parkinsonism and Related Dis 2007; 13: 421-424.
  112. Tinazzi M.Parkinson's disease and lower limb somatosensory evoked potentials: Apomorphine-induced relief of the akinetic-rigid syndrome and vertex P37-N50 potentials. J Neurological Scie 1999; 164: 2: 163-171.
  113. Toda K., Tachibana H., Sugita M., Konishi K.P300 and Reaction Time in Parkinson's Disease. J Geriat Psychiat and Neurol 1993; 6: 3: 131-136.
  114. Tohgi H., Abe T., Hashiguchi K. et al.A significant reduction of putative transmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease and spinocerebellar degeneration. Neurosci Lett 1991; 126: 2: 155-158.
  115. Verstappen C.C., Bloem B.R., Haaxma C.A. et al.Diagnostic value of asymmetric striatal D2 receptor upregulation in Parkinson's disease: an [123I]IBZM and [123I]FP-CIT SPECT study. Eur J Nucl Med Mol Imaging 2007; 34: 502-507.
  116. Walter U., Wittstock M., Benecke R., Dressier D.Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease. J Neural Transm 2002; 109: 191-196.
  117. Wenning G.K., Litvan I., Verny M. et al.Is EEG useful in differential diagnosis of parkinsonism? Parkinsonism and Related Dis 1998; 4: 79-80.
  118. Younes-Mhenni S., Frih-Ayed M., Kerkeni A. et al.Peripheral blood markers of oxidative stress in Parkinson's disease. Eur Neurol 2007; 58: 2: 78-83.
  119. Young R.R.Summary Part I: Tremor. In: R. Benecke, V. Conrad, C.D. Marsden (eds.). Motor Disturbances I London: Academic Press 1987; 79-85.
  120. Yylmaz S., Karaly E., Tokmak A. et al.Auditory evaluation in Parkinsonian patients. Eur Arch of Oto-Rhino-Laryngol 2009; 266: 5: 669-671.
  121. Zesiewicz T.A., Carter S.N., Sullivan K.L. et al.Initial Management of Parkinson's Disease in a Florida Community. J Applied Res 2004; 4: 1: 95-98.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.